FGFR2 fusions assessed by NGS, FISH, and immunohistochemistry in intrahepatic cholangiocarcinoma
Journal of Gastroenterology · 2025-02 · 60 (2) · 235-246
DOI: 10.1007/s00535-024-02175-y ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gastroenterology, online erschienen am 13.11.2024. Verfasst von Zi Cao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical R…. Hauptthemen laut MEDLINE: Receptor, Fibroblast Growth Factor, Type 2, Cholangiocarcinoma, Bile Duct Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: National Natural Science Foundation of China, the Key Project in 14th Five-Year Plan Special for Cancer Prevention and Treatment Research from Tianjin Cancer Institute, the Construction Project of Cancer Precision Diagnosis and Drug Treatment Technology from TUCIH.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Tianjin Key Laboratory of Digestive Cancer,…
- Department of Pancreatic Carcinoma, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Tianjin Key Laboratory of Digest…
ORCID-Profile: Yan Sun
Förderung
- National Natural Science Foundation of China
- the Key Project in 14th Five-Year Plan Special for Cancer Prevention and Treatment Research from Tianjin Cancer Institute
- the Construction Project of Cancer Precision Diagnosis and Drug Treatment Technology from TUCIH
- Tianjin Key Medical Discipline (Pathology) Construction Project
Zitieren
APA
Cao, Z., Yang, Y., Liu, S., Sun, L., Liu, Y., Luo, Y., Wang, J., & Sun, Y. (2025). FGFR2 fusions assessed by NGS, FISH, and immunohistochemistry in intrahepatic cholangiocarcinoma. Journal of Gastroenterology, 60(2), 235-246. https://doi.org/10.1007/s00535-024-02175-y
Vancouver
Cao Z, Yang Y, Liu S, Sun L, Liu Y, Luo Y, et al. FGFR2 fusions assessed by NGS, FISH, and immunohistochemistry in intrahepatic cholangiocarcinoma. Journal of Gastroenterology. 2025;60(2):235-246. doi:10.1007/s00535-024-02175-y
BibTeX
@article{Cao2025,
author = {Cao, Zi and Yang, Yichen and Liu, Shasha and Sun, Lin and Liu, Yanxue and Luo, Ye and Wang, Jian and Sun, Yan},
title = {FGFR2 fusions assessed by NGS, FISH, and immunohistochemistry in intrahepatic cholangiocarcinoma},
journal = {Journal of Gastroenterology},
year = {2025},
volume = {60},
number = {2},
pages = {235--246},
doi = {10.1007/s00535-024-02175-y}
}
EUVIMED